HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susan Band Horwitz Selected Research

discodermolide

1/2018Improved Dose-Response Relationship of (+)-Discodermolide-Taxol Hybrid Congeners.
1/2011Resistance to discodermolide, a microtubule-stabilizing agent and senescence inducer, is 4E-BP1-dependent.
1/2006Potentiation of taxol efficacy and by discodermolide in ovarian carcinoma xenograft-bearing mice.
3/2005The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence.
7/2004Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
4/2002Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susan Band Horwitz Research Topics

Disease

32Neoplasms (Cancer)
01/2020 - 06/2002
11Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 10/2003
11Carcinoma (Carcinomatosis)
01/2018 - 06/2002
4Lung Neoplasms (Lung Cancer)
01/2014 - 07/2004
4Breast Neoplasms (Breast Cancer)
04/2013 - 07/2002
4Aneuploidy (Aneuploid)
01/2006 - 04/2002
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2007 - 11/2001
2Neoplasm Metastasis (Metastasis)
01/2014 - 07/2008
2Carcinogenesis
08/2012 - 07/2008
2Ovarian Epithelial Carcinoma
11/2010 - 12/2005
1Residual Neoplasm
04/2013
1Carcinosarcoma
04/2009
1Disease Progression
04/2009
1Liver Neoplasms (Liver Cancer)
07/2008
1Hematologic Neoplasms (Hematological Malignancy)
06/2008
1Sarcoma (Soft Tissue Sarcoma)
12/2007
1Adenocarcinoma
11/2007
1Substance-Related Disorders (Drug Abuse)
06/2005
1Tetraploidy
11/2003

Drug/Important Bio-Agent (IBA)

20Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 11/2001
12TubulinIBA
01/2018 - 07/2002
9Pharmaceutical PreparationsIBA
11/2016 - 06/2002
6Excipients (Suspending Agents)IBA
01/2018 - 04/2002
6discodermolideIBA
01/2018 - 04/2002
6epothilone B (EPO906)IBA
01/2014 - 04/2002
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2016 - 06/2002
4taxaneIBA
01/2020 - 02/2004
4ixabepilone (BMS 247550)FDA Link
01/2014 - 07/2002
3Proteins (Proteins, Gene)FDA Link
06/2010 - 07/2002
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2018 - 11/2007
2Taxoids (Taxanes)IBA
01/2018 - 06/2008
2Biological ProductsIBA
01/2018 - 09/2011
2human ERBB2 proteinIBA
04/2013 - 04/2009
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2013 - 01/2011
2Hormones (Hormone)IBA
04/2013 - 04/2009
2Biomarkers (Surrogate Marker)IBA
04/2013 - 06/2010
2Protein Isoforms (Isoforms)IBA
08/2012 - 06/2002
22- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA
12/2007 - 04/2005
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2003 - 07/2002
1ParaffinIBA
01/2018
1eribulinFDA Link
11/2016
1Galectin 1 (LGALS1)IBA
01/2014
1Galectins (Galectin)IBA
01/2014
1Estrogen ReceptorsIBA
04/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2013
1A-Form DNA (A-DNA)IBA
01/2011
1Epithelial Cell Adhesion MoleculeIBA
11/2010
1AntigensIBA
11/2010
1Surface Antigens (Surface Antigen)IBA
11/2010
1Insulin-Like PeptidesIBA
06/2010
1AntibodiesIBA
06/2010
1Progesterone Receptors (Progesterone Receptor)IBA
04/2009
1Somatomedin Receptors (Somatomedin Receptor)IBA
04/2009
1Growth Factor ReceptorsIBA
04/2009
1Estrogen Receptor alphaIBA
04/2009
1Estrogen Receptor betaIBA
04/2009
1Vinca AlkaloidsIBA
06/2008
1vinflunineIBA
06/2008
1ridaforolimusIBA
12/2007
1Protein Kinases (Protein Kinase)IBA
12/2007
1Sirolimus (Rapamycin)FDA Link
12/2007
1TOR Serine-Threonine KinasesIBA
12/2007
1mirdametinibIBA
12/2007
1Drug CombinationsIBA
01/2006
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
04/2005
1U 0126 (UO 126)IBA
04/2005
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2005
1Docetaxel (Taxotere)FDA Link
02/2004
1Indicators and Reagents (Reagents)IBA
11/2003
1Epothilones (Epothilone)IBA
10/2003
1multidrug resistance-associated protein 1IBA
07/2002
1Serine (L-Serine)FDA Link
06/2002
1Antimitotic AgentsIBA
06/2002
1NocodazoleIBA
04/2002
1Vinblastine (Vinblastine Sulfate)FDA Link
04/2002
1ColchicineFDA LinkGeneric
04/2002
1Antineoplastic Agents (Antineoplastics)IBA
11/2001

Therapy/Procedure

5Therapeutics
01/2015 - 01/2006
3Drug Therapy (Chemotherapy)
01/2020 - 04/2013
1Salpingectomy
01/2018
1Neoadjuvant Therapy
04/2013